Long-Acting Cabotegravir for HIV Prevention

This Viewpoint discusses the recent FDA approval of cabotegravir, the first injectable medication to help prevent HIV infection, and how its effectiveness may b

Related Keywords

Chris Beyrer ,Jeremiah Johnson ,Joshuam Sharfstein ,Centers For Disease ,Gilead Sciences ,Human Services ,Health Resources ,World Health Organization ,Drug Administration ,National Alliance Of State Territorial ,Hepatitis Policy Institute ,Services Administration ,Department Of Health ,Us Preventive Services Task ,Johns Hopkins Bloomberg School Of Public Health ,University Of Virginia ,Us Department Of Health ,Viiv Healthcare ,Disease Control ,Services Task Force ,Health Policy ,Johns Hopkins Bloomberg School ,Public Health ,Interest Disclosures ,Arnold Ventures ,National Alliance ,